Filing Details
- Accession Number:
- 0001299130-21-000087
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-24 20:50:00
- Reporting Period:
- 2021-02-22
- Accepted Time:
- 2021-02-24 20:50:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1299130 | Pacific Biosciences Of California Inc. | PACB | Laboratory Analytical Instruments (3826) | 161590339 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1317102 | Michael Hunkapiller | Pacific Biosciences Of California, Inc. 1305 O'Brien Drive Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-22 | 45,689 | $6.14 | 894,094 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-02-22 | 45,890 | $5.72 | 939,984 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-02-22 | 45,967 | $7.87 | 985,951 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-02-22 | 45,686 | $5.27 | 1,031,637 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-02-22 | 45,895 | $2.63 | 1,077,532 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-22 | 57,260 | $37.17 | 1,020,272 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-22 | 33,491 | $38.08 | 986,781 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-22 | 38,360 | $39.15 | 948,421 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-22 | 57,902 | $40.28 | 890,519 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-22 | 42,114 | $41.06 | 848,405 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-02-23 | 86,084 | $6.14 | 934,489 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-02-23 | 86,065 | $5.72 | 1,020,554 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-02-23 | 86,022 | $7.87 | 1,106,576 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-02-23 | 86,047 | $5.27 | 1,192,623 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-02-23 | 29,103 | $2.63 | 1,221,726 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-23 | 24,100 | $30.90 | 1,197,626 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-23 | 28,595 | $31.71 | 1,169,031 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-23 | 18,259 | $32.98 | 1,150,772 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-23 | 42,378 | $34.22 | 1,108,394 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-23 | 113,308 | $35.10 | 995,086 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-23 | 74,119 | $35.99 | 920,967 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-23 | 72,562 | $36.85 | 848,405 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-02-22 | 45,689 | $0.00 | 45,689 | $6.14 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-02-22 | 45,890 | $0.00 | 45,890 | $5.72 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-02-22 | 45,967 | $0.00 | 45,967 | $7.87 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-02-22 | 45,686 | $0.00 | 45,686 | $5.27 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-02-22 | 45,895 | $0.00 | 45,895 | $2.63 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-02-23 | 86,084 | $0.00 | 86,084 | $6.14 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-02-23 | 86,065 | $0.00 | 86,065 | $5.72 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-02-23 | 86,022 | $0.00 | 86,022 | $7.87 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-02-23 | 86,047 | $0.00 | 86,047 | $5.27 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-02-23 | 29,103 | $0.00 | 29,103 | $2.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 121,811 | 2024-03-17 | No | 4 | M | Direct | |
| 354,110 | 2025-03-16 | No | 4 | M | Direct | |
| 354,033 | 2026-03-15 | No | 4 | M | Direct | |
| 354,314 | 2027-02-15 | No | 4 | M | Direct | |
| 54,105 | 2028-03-15 | No | 4 | M | Direct | |
| 35,727 | 2024-03-17 | No | 4 | M | Direct | |
| 268,045 | 2025-03-16 | No | 4 | M | Direct | |
| 268,011 | 2026-03-15 | No | 4 | M | Direct | |
| 268,267 | 2027-02-15 | No | 4 | M | Direct | |
| 25,002 | 2028-03-15 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2020.
- This sale price represents the weighted average sale price of the shares sold ranging from $36.65 to $37.64 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- This sale price represents the weighted average sale price of the shares sold ranging from $37.65 to $38.64 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- This sale price represents the weighted average sale price of the shares sold ranging from $38.67 to $39.66 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- This sale price represents the weighted average sale price of the shares sold ranging from $39.67 to $40.66 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- This sale price represents the weighted average sale price of the shares sold ranging from $40.67 to $41.62 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- This sale price represents the weighted average sale price of the shares sold ranging from $30.37 to $31.36 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- This sale price represents the weighted average sale price of the shares sold ranging from $31.38 to $32.34 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- This sale price represents the weighted average sale price of the shares sold ranging from $32.41 to $33.39 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- This sale price represents the weighted average sale price of the shares sold ranging from $33.57 to $34.56 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- This sale price represents the weighted average sale price of the shares sold ranging from $34.57 to $35.56 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- This sale price represents the weighted average sale price of the shares sold ranging from $35.57 to $36.54 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- This sale price represents the weighted average sale price of the shares sold ranging from $36.57 to $37.21 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- The shares subject to the option are fully vested and exercisable.
- The shares subject to the option vest in equal monthly installments over a four year period, provided that the Reporting Person continues to serve through each vesting date.
Billionaire Hedge Funds
